Published • loading... • Updated
Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future
Summary by BizToc
3 Articles
3 Articles
They are among the most expensive for both the state and the individual citizens: because they are very popular and the patent will expire only in 5 years
·Italy
Read Full Article
New Nordisk CEO Mike Doustdar has been ahead of a restructuring of the company for a year. According to him, investors still underestimate the potential of the company's drugs The post The creator of Ozempic needs a new chapter. The pills can be the answer appeared first on InfoMoney.
Coverage Details
Total News Sources3
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
